CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a multicenter, randomized, open-label study of Tumor Treating Fields (TTFields) at 150 kHz to the thorax using the NovoTTF-200T Syst-...
Phase 2
Indianapolis, Indiana, United States and 23 other locations
This open-label, non-randomized Phase II trial is designed to assess the safety and tolerability of GT103 in combination with pembrolizumab ...
Phase 2
Indianapolis, Indiana, United States and 5 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...
Phase 3
Indianapolis, Indiana, United States and 286 other locations
This study is an open label, multicenter, randomized phase II trial of consolidation immunotherapy with either nivolumab alone or the combination of...
Phase 2
Indianapolis, Indiana, United States and 11 other locations
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...
Phase 3
Indianapolis, Indiana, United States and 262 other locations
in previously untreated patients with locally advanced or metastatic non-squamous Non-Small Cell Lung Ca...
Phase 3
Indianapolis, Indiana, United States and 206 other locations
The purpose of this study is to learn the effects of fasting on cancer cells while you get maintenance treatment....
Indianapolis, Indiana, United States and 3 other locations
The purpose of eVOLVE-Lung02 is to test the effectiveness (efficacy) and measure the safety of volrustomig in combination with chemotherapy ...
Phase 3
Indianapolis, Indiana, United States and 279 other locations
observation following surgical resection in patients with stage I non-small cell lung cancer (NSCLC) wit...
Phase 2
Indianapolis, Indiana, United States and 12 other locations
This phase II Expanded Lung-MAP treatment trial tests tepotinib with or without ramucirumab for the treatment of patients with advanced non...
Phase 2
Indianapolis, Indiana, United States and 221 other locations
Clinical trials
Research sites
Resources
Legal